The Prognostic Significance of Transient Receptor Potential Canonical 1 and Its Association with Vascular Endothelial Growth Factor Receptor 2 in Papillary Thyroid Carcinoma Patients

  • 0Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital.

|

|

Summary

This summary is machine-generated.

Transient receptor potential canonical 1 (TRPC1) is linked to increased invasion and relapse risk in papillary thyroid carcinoma (PTC). Higher TRPC1 levels correlate with poorer disease-free survival and elevated vascular endothelial growth factor receptor 2 (VEGFR2) in PTC patients.

Area Of Science

  • Oncology
  • Molecular Biology
  • Pathology

Background

  • Transient receptor potential canonical 1 (TRPC1) is implicated in cancer cell proliferation and metastasis.
  • The role of TRPC1 in papillary thyroid carcinoma (PTC) and its association with vascular endothelial growth factor receptor 2 (VEGFR2) remain unclear.

Purpose Of The Study

  • To investigate the prognostic significance of TRPC1 expression in PTC.
  • To examine the correlation between TRPC1 and VEGFR2 in PTC patients.

Main Methods

  • Retrospective analysis of TRPC1 and VEGFR2 immunohistochemistry (IHC) scores in 287 PTC patients and 30 thyroid benign lesion (TBL) patients.
  • Correlation of TRPC1 IHC scores with clinicopathological features and patient survival (DFS, OS).
  • Time-dependent area under the curve (AUC) analysis for relapse and death risk prediction.

Main Results

  • TRPC1 expression was significantly higher in PTC tissues compared to TBL tissues (P = 0.006).
  • Elevated TRPC1 scores correlated with extrathyroidal invasion (P = 0.028) and pathological node stage 1 (P = 0.011).
  • TRPC1 IHC score > 3 was associated with shortened disease-free survival (DFS) (P = 0.005) and overall survival (OS) (P = 0.020), and independently predicted shorter DFS (HR = 2.948, P = 0.045).
  • TRPC1 expression showed a positive association with VEGFR2 expression in PTC (P = 0.010).

Conclusions

  • TRPC1 expression is associated with tumor invasion and lymph node metastasis in PTC.
  • High TRPC1 expression (>3) serves as an independent predictor of shorter DFS in PTC patients.
  • TRPC1 is linked to increased VEGFR2 expression and elevated disease relapse risk in PTC.

Related Concept Videos

Mitogens and the Cell Cycle 02:38

6.4K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

mTOR Signaling and Cancer Progression 03:03

3.8K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Regulation of Angiogenesis and Blood Supply 01:24

2.5K

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Transducer Mechanism: Enzyme-Linked Receptors 01:27

2.4K

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Receptor tyrosine kinases:

Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...

Interactions Between Signaling Pathways 01:19

6.3K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

PI3K/mTOR/AKT Signaling Pathway 01:22

3.5K

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...